Back to search

Article

Fully Human Bifunctional Intrabodies Achieve Graded Reduction of Intracellular Tau and Rescue Survival of <i>MAPT</i> Mutation iPSC-derived Neurons

2024-06-01

Abstract excerpt

Tau protein aggregation is a hallmark of several neurodegenerative diseases, including Alzheimer’s disease, frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP), spurring development of tau-lowering therapeutic strategies. Here, we report fully human bifunctional anti-tau-PEST intrabodies that bind the mid-domain of tau to block aggregation and degrade tau via the proteasome using the ornithine d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
38135587-413c-55a0-9281-a8d4265d8688
DOI
10.1101/2024.05.28.596248
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fully Human Bifunctional Intrabodies Achieve Graded Reduction of Intracellular Tau and Rescue Survival of <i>MAPT</i> Mutation iPSC-derived NeuronsDOI 10.1101/2024.05.28.596248
Select a neighboring publication to make it the new centre.